[1] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385(9963):117 − 71. https://doi.org/10.1016/s0140-6736(14)61682-2CrossRef
[2] Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21(3):195 − 210. https://doi.org/10.1038/s41579-022-00807-9CrossRef
[3] Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill 2022;27(19):2100746. https://doi.org/10.2807/1560-7917.Es.2022.27.19.2100746CrossRef
[4] WHO. Disease Outbreak News. Upsurge of respiratory illnesses among children-northern China. 2023. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494. [2023-12-17
[5] Looi MK. China: rising cases of respiratory disease and pneumonia spark WHO concern. BMJ 2023;383:2770. https://doi.org/10.1136/bmj.p2770CrossRef
[6] Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 2019;7(8):e1031 − 45. https://doi.org/10.1016/s2214-109x(19)30264-5CrossRef
[7] Langedijk AC, Bont LJ. Respiratory syncytial virus infection and novel interventions. Nat Rev Microbiol 2023;21(11):734 − 49. https://doi.org/10.1038/s41579-023-00919-wCrossRef
[8] Li Y, Wu ZY, Yan Y, Shi Y, Huang JM, Du H, et al. Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China. Int J Infect Dis 2024;139:6 − 12. https://doi.org/10.1016/j.ijid.2023.11.019CrossRef
[9] Meyer Sauteur PM, Beeton ML. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe 2024;5(2):e100 − 1. https://doi.org/10.1016/s2666-5247(23)00344-0CrossRef
[10] Liu WJ, Liu SL. A tale of two cities: from influenza HxNy to SARS-CoV-z. China CDC Wkly 2021;3(49):1052 − 6. https://doi.org/10.46234/ccdcw2021.256CrossRef